Zacks
0
All posts from Zacks
Zacks in Our Research. Your Success.,

Alnylam Pharmaceuticals (ALNY) Soars: Stock Adds 51.7% in Session

Alnylam Pharmaceuticals, Inc. ALNY was a big mover last session, as the company saw its shares rise nearly 52% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $72.53 to $88.91 in the past one-month time frame.

The stock gained after the company reported positive Phase 3 results from its new drug, patisiran, which is a treatment for patients with hereditary ATTR amyloidosis with polyneuropathy.

The company has seen three positive estimate revisions in the past few months, while its Zacks Consensus Estimate for the current quarter has also moved higher over the past few months, suggesting that more solid trading could be ahead for Alnylam Pharmaceuticals. So make sure to keep an eye on this stock going forward to see if this recent jump can turn into more strength down the road.

Alnylam Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.

Investors interested in the Medical - Biomedical and Genetics industry may consider Alexion Pharmaceuticals, Inc. ALXN, which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is ALNY going up? Or down? Predict to see what others think:Up or Down

Will You Make a Fortune on the Shift to Electric Cars?

Here's another stock idea to consider. Much like petroleum 150 years ago, lithium power may soon shake the world, creating millionaires and reshaping geo-politics. Soon electric vehicles (EVs) may be cheaper than gas guzzlers. Some are already reaching 265 miles on a single charge.

With battery prices plummeting and charging stations set to multiply, one company stands out as the #1 stock to buy according to Zacks research.

It's not the one you think.

See This Ticker Free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alexion Pharmaceuticals, Inc. (ALXN): Free Stock Analysis Report
 
Alnylam Pharmaceuticals, Inc. (ALNY): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research